See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411685_2023_Vistagen_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001411685, Vistagen Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 70,998,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 414,300 |
| 3 | remainder_Assets | 3,231,100 |
| 4 | LiabilitiesCurrent | 5,765,100 |
| 5 | LiabilitiesNoncurrent | 4,163,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,480,000 |
| 9 | ResearchAndDevelopmentExpense | 35,407,800 |
| 10 | remainder_Expenses | 3,400 |
| 11 | remainder_Revenues | 1,108,900 |
| 12 | remainder_NetIncome | 19,900 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 74,643,400 |
| 1 | Liabilities | 9,928,100 |
| 2 | Expenses | 48,891,200 |
| 3 | Revenues | 1,108,900 |
| 4 | StockholdersEquity | 64,715,300 |
| 5 | NetIncome | -47,762,400 |
| 6 | ComprehensiveNetIncome | -47,762,400 |
| 7 | BaseVar | 67,295,750 |
| 8 | EconomicCapitalRatio | 1.50 |
Edgar->Model Mapping
Feature Distribution
Change over Time
